Pharmacovigilance is Not Just About Compliance



Andrea Charles
03/23/2011

Dr. Viraj Suvarna, Medical Director and Head of Medical Affairs at Boehringer Ingelheim, joins Andrea Charles from Pharma IQ to discuss the importance of training and re-training field operatives to report adverse drug events (ADEs) and how understanding the risk-benefit profile of your product can maximise benefit and minimising risk, by making sure the right drug, goes to the right patient, at the right time.   

[inlinead]